LINCOLNSHIRE, Ill.- Stephen M. Simes, president and CEO of BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX), will present at the BIO International Convention in Atlanta, Georgia, on Tuesday, May 19, 2009 at 4:20 pm EDT. The BIO International Convention (BIO) is a symposium including leading pharmaceutical and biotechnology companies presenting to institutional investors, portfolio managers, analysts and the media, to discuss emerging trends in the sector.
Mr. Simes will discuss the LibiGel® (testosterone gel) clinical development plan and recent primary research data indicating the potential size of the U.S. market for BioSante's LibiGel in the treatment of female sexual dysfunction.
No comments:
Post a Comment